Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Liolios

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecular Pharmaceutics|April 25, 2022
Investigation of Tumor Cells and Receptor-Ligand Simulation Models for the Development of PET Imaging Probes Targeting PSMA and GRPR and a Possible Crosstalk between the Two ReceptorsChristos Liolios, Christos Patsis, George Lambrinidis, et al.
Frontiers in Nuclear Medicine|October 9, 2024
Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancerDanae Efremia Bajwa, Evangelia-Alexandra Salvanou, Maria Theodosiou, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|April 11, 2019
Designing tracers for PET imaging of the urokinase-type plasminogen activator receptor from a cyclic uPA-derived peptide: first in vitro evaluationsAnja Wacker, Ulrike Bauder-Wüst, Martin Schäfer, et al.
Nanomaterials (Basel, Switzerland)|July 27, 2022
Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic AgentsEvangelia-Alexandra Salvanou, Argiris Kolokithas-Ntoukas, Christos Liolios, et al.
International Journal of Pharmaceutics|July 12, 2022
Synthesis and in vitro proof-of-concept studies on bispecific iron oxide magnetic nanoparticles targeting PSMA and GRP receptors for PET/MR imaging of prostate cancerChristos Liolios, Theodora S Koutsikou, Evangelia-Alexandra Salvanou, et al.
Bioorganic Chemistry|May 20, 2020
Synthesis, characterization and evaluation of <sup>68</sup>Ga labelled monomeric and dimeric quinazoline derivatives of the HBED-CC chelator targeting the epidermal growth factor receptorChristos Liolios, Antonio Shegani, Ioanna Roupa, et al.
Journal of Chemical Information and Modeling|April 23, 2016
Alchemical Free Energy Calculations and Isothermal Titration Calorimetry Measurements of Aminoadamantanes Bound to the Closed State of Influenza A/M2TMHarris Ioannidis, Antonios Drakopoulos, Christina Tzitzoglaki, et al.
Bioconjugate Chemistry|August 9, 2017
Improving the Imaging Contrast of <sup>68</sup>Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic PropertiesAnn-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, et al.
International Journal of Pharmaceutics|March 23, 2015
Specific in vitro binding of a new (99m)Tc-radiolabeled derivative of the C-terminal decapeptide of prothymosin alpha on human neutrophilsChrysoula-Evangelia Karachaliou, Christos Liolios, Charalampos Triantis, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate CancerChristos Liolios, Danai Bouziotis, Wiebke Sihver, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Pharmaceutics|April 25, 2022
Investigation of Tumor Cells and Receptor-Ligand Simulation Models for the Development of PET Imaging Probes Targeting PSMA and GRPR and a Possible Crosstalk between the Two ReceptorsChristos Liolios, Christos Patsis, George Lambrinidis, et al.
Frontiers in Nuclear Medicine|October 9, 2024
Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancerDanae Efremia Bajwa, Evangelia-Alexandra Salvanou, Maria Theodosiou, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|April 11, 2019
Designing tracers for PET imaging of the urokinase-type plasminogen activator receptor from a cyclic uPA-derived peptide: first in vitro evaluationsAnja Wacker, Ulrike Bauder-Wüst, Martin Schäfer, et al.
Nanomaterials (Basel, Switzerland)|July 27, 2022
Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic AgentsEvangelia-Alexandra Salvanou, Argiris Kolokithas-Ntoukas, Christos Liolios, et al.
International Journal of Pharmaceutics|July 12, 2022
Synthesis and in vitro proof-of-concept studies on bispecific iron oxide magnetic nanoparticles targeting PSMA and GRP receptors for PET/MR imaging of prostate cancerChristos Liolios, Theodora S Koutsikou, Evangelia-Alexandra Salvanou, et al.
Bioorganic Chemistry|May 20, 2020
Synthesis, characterization and evaluation of <sup>68</sup>Ga labelled monomeric and dimeric quinazoline derivatives of the HBED-CC chelator targeting the epidermal growth factor receptorChristos Liolios, Antonio Shegani, Ioanna Roupa, et al.
Journal of Chemical Information and Modeling|April 23, 2016
Alchemical Free Energy Calculations and Isothermal Titration Calorimetry Measurements of Aminoadamantanes Bound to the Closed State of Influenza A/M2TMHarris Ioannidis, Antonios Drakopoulos, Christina Tzitzoglaki, et al.
Bioconjugate Chemistry|August 9, 2017
Improving the Imaging Contrast of <sup>68</sup>Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic PropertiesAnn-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, et al.
International Journal of Pharmaceutics|March 23, 2015
Specific in vitro binding of a new (99m)Tc-radiolabeled derivative of the C-terminal decapeptide of prothymosin alpha on human neutrophilsChrysoula-Evangelia Karachaliou, Christos Liolios, Charalampos Triantis, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate CancerChristos Liolios, Danai Bouziotis, Wiebke Sihver, et al.
Pageof 3